69 related articles for article (PubMed ID: 8742419)
1. Inhibition of [3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin.
Balcar VJ; Dias LS; Li Y; Bennett MR
Neuroreport; 1995 Dec; 7(1):69-72. PubMed ID: 8742419
[TBL] [Abstract][Full Text] [Related]
2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
3. Methionine sulfoximine shows excitotoxic actions in rat cortical slices.
Shaw CA; Bains JS; Pasqualotto BA; Curry K
Can J Physiol Pharmacol; 1999 Nov; 77(11):871-7. PubMed ID: 10593660
[TBL] [Abstract][Full Text] [Related]
4. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
Christie JM; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
[TBL] [Abstract][Full Text] [Related]
5. P2 purinoceptor blocker suramin antagonises NMDA receptors and protects against excitatory behaviour caused by NMDA receptor agonist (RS)-(tetrazol-5-yl)-glycine in rats.
Ong WY; Motin LG; Hansen MA; Dias LS; Ayrout C; Bennett MR; Balcar VJ
J Neurosci Res; 1997 Sep; 49(5):627-38. PubMed ID: 9302084
[TBL] [Abstract][Full Text] [Related]
6. Glutamate receptors in the cingulate cortex, hippocampus, and cerebellar vermis of alcoholics.
Freund G; Anderson KJ
Alcohol Clin Exp Res; 1999 Jan; 23(1):1-6. PubMed ID: 10029196
[TBL] [Abstract][Full Text] [Related]
7. Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
Suzuki E; Kessler M; Montgomery K; Arai AC
Mol Pharmacol; 2004 Dec; 66(6):1738-47. PubMed ID: 15448189
[TBL] [Abstract][Full Text] [Related]
8. Modulation of a competitive N-methyl-D-aspartate receptor antagonist binding by zinc oxide.
Terse PS; Komiskey HL
Brain Res; 1997 Jan; 744(2):347-50. PubMed ID: 9027396
[TBL] [Abstract][Full Text] [Related]
9. Two affinity states of N-methyl-D-aspartate recognition sites: modulation by cations.
Mukhin A; Kovaleva ES; London ED
J Pharmacol Exp Ther; 1997 Aug; 282(2):945-54. PubMed ID: 9262362
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
Radenovic L; Selakovic V
Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
[TBL] [Abstract][Full Text] [Related]
11. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
Nörenberg W; Wirkner K; Illes P
Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
[TBL] [Abstract][Full Text] [Related]
12. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
Rettinger J; Braun K; Hochmann H; Kassack MU; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
Neuropharmacology; 2005 Mar; 48(3):461-8. PubMed ID: 15721178
[TBL] [Abstract][Full Text] [Related]
13. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex.
Berger ML; Rebernik P
J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action.
Javitt DC; Duncan L; Balla A; Sershen H
Mol Psychiatry; 2005 Mar; 10(3):275-87. PubMed ID: 15278098
[TBL] [Abstract][Full Text] [Related]
15. A partial agonist model used in the allosteric modulation of the NMDA receptor.
Robichon R; Randall PK; Leslie SW
Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709
[TBL] [Abstract][Full Text] [Related]
16. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
[TBL] [Abstract][Full Text] [Related]
17. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
18. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor binding in adult rat brain after several chronic ethanol treatment protocols.
Rudolph JG; Walker DW; Iimuro Y; Thurman RG; Crews FT
Alcohol Clin Exp Res; 1997 Nov; 21(8):1508-19. PubMed ID: 9394125
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
Zhang XX; Bunney BS; Shi WX
Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
